Sci-Tech Press South Dakota
SEE OTHER BRANDS

Get your science and technology news from South Dakota

Sci-Tech Press South Dakota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Press South Dakota.

Press releases published on July 30, 2025

NVIDIA Sets Conference Call for Second-Quarter Financial Results

NVIDIA Sets Conference Call for Second-Quarter Financial Results

SANTA CLARA, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- NVIDIA will host a conference call on Wednesday, August 27, at 2 p.m. PT (5 p.m. ET) to discuss its financial results for the second quarter of fiscal year 2026, which ended July 27, 2025. The call …

Tarsus to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025

Tarsus to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025

IRVINE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on Wednesday, August 6, 2025, to report its second quarter 2025 financial results …

Bridgehold Launches New AI-Driven Blockchain Forensics Suite Following Endorsement from Cybersecurity Experts

Bridgehold Launches New AI-Driven Blockchain Forensics Suite Following Endorsement from Cybersecurity Experts

London UK, July 30, 2025 (GLOBE NEWSWIRE) -- Bridgehold reviews are making headlines as the company today announced the launch of its new AI-driven blockchain forensics suite, a timely move that follows official endorsements from top cybersecurity experts …

SciSparc Announces Updates Regarding Proposed Merger; Form F-4 Registration Statement Has Been Declared Effective by SEC

SciSparc Announces Updates Regarding Proposed Merger; Form F-4 Registration Statement Has Been Declared Effective by SEC

TEL AVIV, Israel, July 30, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the “Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, …

Inoxoft Launches Offline AI Tool for On-Device Text Classification

Inoxoft Launches Offline AI Tool for On-Device Text Classification

PHILADELPHIA, July 30, 2025 (GLOBE NEWSWIRE) -- Inoxoft, a custom software development company, has announced the release of WhiteLightning, an open-source CLI tool that enables developers to train and run fast, lightweight text classifiers entirely …

Apyx Medical Corporation to Participate in the Canaccord Genuity 45th Annual Growth Conference

Apyx Medical Corporation to Participate in the Canaccord Genuity 45th Annual Growth Conference

CLEARWATER, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion® and the AYON Body …

Duos Technologies Group, Inc. Announces Proposed Public Offering of Common Stock

Duos Technologies Group, Inc. Announces Proposed Public Offering of Common Stock

JACKSONVILLE, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- Duos Technologies Group, Inc. (“Duos” or the “Company”) (Nasdaq: DUOT) a provider of adaptive, versatile and streamlined Edge Data Center (“EDC”) solutions tailored to meet evolving needs in any …

Brag House Announces Closing of $15 Million Private Placement

Brag House Announces Closing of $15 Million Private Placement

NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Brag House Holdings, Inc. (NASDAQ: TBH) (“Brag House” or the “Company”) the Gen Z engagement platform operating at the intersection of gaming, college sports, and digital media, announces today that it has closed …

Arvinas to Report Second Quarter 2025 Financial Results on August 6, 2025

Arvinas to Report Second Quarter 2025 Financial Results on August 6, 2025

NEW HAVEN, Conn., July 30, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will review financial results from …

Tenable Announces Second Quarter 2025 Financial Results

Tenable Announces Second Quarter 2025 Financial Results

Revenue of $247.3 million, up 12% year-over-year. Calculated current billings of $238.6 million, up 8% year-over-year. GAAP operating margin of (3)%; Non-GAAP operating margin of 19%. Net cash provided by operating activities of $42.5 million; Unlevered …

Revolution Medicines to Report Financial Results for Second Quarter 2025 After Market Close on August 6, 2025

Revolution Medicines to Report Financial Results for Second Quarter 2025 After Market Close on August 6, 2025

REDWOOD CITY, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that it will report financial …

SPS Commerce Reports Second Quarter 2025 Financial Results

SPS Commerce Reports Second Quarter 2025 Financial Results

Company delivers 98th consecutive quarter of topline growth Second quarter 2025 revenue grew 22% and recurring revenue grew 24% from the second quarter of 2024 MINNEAPOLIS, July 30, 2025 (GLOBE NEWSWIRE) -- SPS Commerce, Inc. (NASDAQ: SPSC), a leader in …

Aligos Therapeutics to Announce 2nd Quarter 2025 Financial Results on August 6, 2025

Aligos Therapeutics to Announce 2nd Quarter 2025 Financial Results on August 6, 2025

SOUTH SAN FRANCISCO, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …

Climb Global Solutions Reports Second Quarter 2025 Results

Climb Global Solutions Reports Second Quarter 2025 Results

EATONTOWN, N.J., July 30, 2025 (GLOBE NEWSWIRE) -- Climb Global Solutions, Inc. (NASDAQ:CLMB) (“Climb” or the “Company”), a value-added global IT channel company providing unique sales and distribution solutions for innovative technology vendors, is …

Applied Digital Reports Fiscal Fourth Quarter and Full Year 2025 Results

Applied Digital Reports Fiscal Fourth Quarter and Full Year 2025 Results

DALLAS, July 30, 2025 (GLOBE NEWSWIRE) -- Applied Digital Corporation (Nasdaq: APLD) ("Applied Digital" or the "Company"), a designer, builder, and operator of next-generation digital infrastructure designed for high-performance computing (“HPC”) …

IMDX World Transplant Congress Late-Breaking Data Potentially Sets New Bar for Predicting Graft Rejection in Kidney Transplant Patients

IMDX World Transplant Congress Late-Breaking Data Potentially Sets New Bar for Predicting Graft Rejection in Kidney Transplant Patients

iMDx first dd-PCR assay to combine relative and absolute measurements of dd-cfDNA into single combined score Data show significantly improved positive predictive value (PPV) for graft rejection, which potentially broadens clinical utility for dd-cfDNA with …

Codexis to Report Second Quarter 2025 Financial Results on August 13

Codexis to Report Second Quarter 2025 Financial Results on August 13

REDWOOD CITY, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced that it will report its financial results …

Pulmonx Reports Second Quarter 2025 Financial Results

Pulmonx Reports Second Quarter 2025 Financial Results

REDWOOD CITY, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported financial results for the second quarter of 2025 …

Eledon Pharmaceuticals to Host a Conference Call to Discuss Updated Data from the Ongoing Phase 1b Trial of Tegoprubart in Kidney Transplantation Being Presented at the World Transplant Congress 2025

Eledon Pharmaceuticals to Host a Conference Call to Discuss Updated Data from the Ongoing Phase 1b Trial of Tegoprubart in Kidney Transplantation Being Presented at the World Transplant Congress 2025

IRVINE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that the company will host a conference call and webcast on Wednesday, August 6, 2025 at 4:30 p.m. ET to discuss updated clinical data …

Dyadic International, Inc. Announces Proposed Public Offering of Common Stock

Dyadic International, Inc. Announces Proposed Public Offering of Common Stock

JUPITER, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic” or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of high-value, precision engineered functional input proteins for use …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions